Frequency of isolation and antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections: a French prospective national survey

被引:49
作者
Decousser, JW
Pina, P
Picot, E
Delalande, C
Pangon, B
Courvalin, P
Allouch, P [1 ]
机构
[1] Ctr Hosp A Mignot, Versailles, France
[2] Inst Pasteur, Paris, France
关键词
bloodstream infection; antimicrobial susceptibility; VRSA; Streptococcus pneumoniae; France;
D O I
10.1093/jac/dkg201
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
All bloodstream strains, total 1463, isolated during a 1 month period in 105 hospitals representing all geographical areas in France were collected to study their antimicrobial susceptibility. The three major species were Escherichia coli, Staphylococcus aureus and coagulase-negative staphylococci. Among the 242 S. aureus, 87 were resistant to methicillin and among those 99% were resistant to ciprofloxacin, 11.5% to gentamicin, 1% to quinupristin/dalfopristin and 8% were heterogeneously resistant to vancomycin. Study of the methicillin-resistant S. aureus indicated that 12 clones had disseminated in French hospitals, six being heterogeneously resistant to vancomycin. Among the Streptococcus pneumoniae, 43% showed decreased susceptibility to the penicillins and 42% to erythromycin. One isolate was highly resistant to fluoroquinolones. Gentamicin, cefotaxime, ciprofloxacin and gatifloxacin resistance was rare in Enterobacteriaceae with 95% of strains susceptible. The incidence of extended-spectrum beta-lactamases was quite low. Moreover more than 25% of Pseudomonas aeruginosa strains were resistant to ciprofloxacin and gentamicin. The magnitude of antibiotic resistance in bloodstream isolates, in particular Gram-positive bacteria, emphasizes the importance of hospital control measures, rational prescribing policies and new vaccine strategies.
引用
收藏
页码:1213 / 1222
页数:10
相关论文
共 43 条
[1]  
[Anonymous], 2002, MMWR MORB MORTAL WKL, V51, P565
[2]   Twenty months of screening for glycopeptide-intermediate Staphylococcus aureus [J].
Aucken, HM ;
Warner, M ;
Ganner, M ;
Johnson, AP ;
Richardson, JF ;
Cookson, BD ;
Livermore, DM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (04) :639-640
[3]   PULSED-FIELD GEL-ELECTROPHORESIS AS A REPLACEMENT FOR BACTERIOPHAGE-TYPING OF STAPHYLOCOCCUS-AUREUS [J].
BANNERMAN, TL ;
HANCOCK, GA ;
TENOVER, FC ;
MILLER, JM .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (03) :551-555
[4]   An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: Risk factors and microbiological associations [J].
Byington, CL ;
Spencer, LY ;
Johnson, TA ;
Pavia, AT ;
Allen, D ;
Mason, EO ;
Kaplan, S ;
Carroll, KC ;
Daly, JA ;
Christenson, JC ;
Samore, MH .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (04) :434-440
[5]  
*CDC, 2002, MMWR-MORBID MORTAL W, V51, P902
[6]   Retrospective screening for heterogeneous vancomycin resistance in diverse Staphylococcus aureus clones disseminated in French hospitals [J].
Chesneau, O ;
Morvan, A ;
El Solh, N .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 (06) :887-890
[7]  
*COM TECHN NAT INF, 1999, CCLIN PARIS NORD WEB
[8]   Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections in the USA, Canada and Latin America [J].
Diekema, DJ ;
Pfaller, MA ;
Jones, RN ;
Doern, GV ;
Kugler, KC ;
Beach, ML ;
Sader, HS .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2000, 13 (04) :257-271
[9]   Streptococcus pneumoniae bacteraemia in Belgium:: differential characteristics in children and the elderly population and implications for vaccine use [J].
Flamaing, J ;
Verhaegen, J ;
Peetermans, WE .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 (01) :43-50
[10]   Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY Antimicrobial Surveillance Program, 1997 and 1998 [J].
Fluit, AC ;
Jones, ME ;
Schmitz, FJ ;
Acar, J ;
Gupta, R ;
Verhoef, J .
CLINICAL INFECTIOUS DISEASES, 2000, 30 (03) :454-460